One is the synthesis method of ATP competitive small molecule AKT inhibitor A443654
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI HAOYUAN MEDCHEMEXPRESS CO LTD
- Publication Date
- 2017-01-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Technical field:
[0002] The invention relates to a method for preparing a compound, in particular to a method for synthesizing ATP competitive small molecule AKT inhibitor A443654.
[0003] Background technique:
[0004] The PI3K / AKT / mTOR signaling pathway is an important signal transduction pathway in cells, which affects cell metabolism, proliferation, transcription, survival and angiogenesis, and is closely related to the occurrence and development of various tumors, and is also associated with diabetes, related to cardiovascular disease. AKT, also known as protein kinase B (protein kinase B, PKB), is a serine / threonine protein kinase. PI3K / AKT signaling is activated in normal tissues, and when the pathway is overactivated, the overexpression of p-AKT may lead to tumor cell death by down-regulating the tumor suppressor protein p53, stimulating protein synthesis, and inhibiting apoptosis. Unlimited value-added. Therefore, inhibiting the activation of this pathway ...